Bard Associates Inc. Sells 1,040 Shares of Stericycle, Inc. (NASDAQ:SRCL)

Bard Associates Inc. lessened its holdings in shares of Stericycle, Inc. (NASDAQ:SRCLFree Report) by 4.2% in the third quarter, according to its most recent filing with the SEC. The firm owned 23,570 shares of the business services provider’s stock after selling 1,040 shares during the period. Bard Associates Inc.’s holdings in Stericycle were worth $1,438,000 as of its most recent filing with the SEC.

Other large investors also recently made changes to their positions in the company. OneDigital Investment Advisors LLC increased its position in Stericycle by 1.3% during the 3rd quarter. OneDigital Investment Advisors LLC now owns 13,723 shares of the business services provider’s stock worth $837,000 after buying an additional 171 shares during the period. Mirova raised its stake in Stericycle by 0.9% in the first quarter. Mirova now owns 47,345 shares of the business services provider’s stock valued at $2,497,000 after purchasing an additional 428 shares in the last quarter. Wealth Enhancement Advisory Services LLC lifted its position in Stericycle by 6.4% during the second quarter. Wealth Enhancement Advisory Services LLC now owns 7,447 shares of the business services provider’s stock worth $433,000 after purchasing an additional 449 shares during the period. Clearstead Trust LLC acquired a new stake in Stericycle during the first quarter worth about $25,000. Finally, Arizona State Retirement System increased its holdings in Stericycle by 1.9% in the 2nd quarter. Arizona State Retirement System now owns 25,915 shares of the business services provider’s stock valued at $1,506,000 after buying an additional 487 shares during the period. Institutional investors and hedge funds own 98.82% of the company’s stock.

Wall Street Analysts Forecast Growth

Separately, StockNews.com assumed coverage on Stericycle in a research note on Tuesday. They issued a “hold” rating for the company. One analyst has rated the stock with a sell rating, four have issued a hold rating and two have given a buy rating to the company. Based on data from MarketBeat, the company has an average rating of “Hold” and a consensus price target of $74.00.

Get Our Latest Report on SRCL

Stericycle Stock Performance

SRCL stock opened at $61.98 on Friday. The firm has a fifty day moving average price of $61.36 and a 200 day moving average price of $57.52. Stericycle, Inc. has a fifty-two week low of $37.78 and a fifty-two week high of $61.99. The company has a debt-to-equity ratio of 0.53, a quick ratio of 1.13 and a current ratio of 1.20. The firm has a market cap of $5.75 billion, a PE ratio of 163.11, a price-to-earnings-growth ratio of 3.38 and a beta of 1.10.

About Stericycle

(Free Report)

Stericycle, Inc, together with its subsidiaries, provides regulated waste and compliance services in the United States, Europe, and internationally. The company offers regulated waste and compliance services, including regulated medical waste, sharps waste management and disposal, pharmaceutical waste management and disposal, chemotherapy waste and disposal, controlled substance waste disposal, healthcare hazardous waste, and integrated waste stream solutions; specialty services, such as MedDrop medication collection kiosks, safe community solutions, SafeDrop sharps mailback solutions, and airport and maritime waste services; medical supply store services, that includes sharps and disposable biohazardous waste containers, infection control supplies, and seal&send medication mail back; and compliance solutions including Steri-Safe compliance solutions.

Featured Articles

Want to see what other hedge funds are holding SRCL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Stericycle, Inc. (NASDAQ:SRCLFree Report).

Institutional Ownership by Quarter for Stericycle (NASDAQ:SRCL)

Receive News & Ratings for Stericycle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stericycle and related companies with MarketBeat.com's FREE daily email newsletter.